Dehydrojuncusol, CAS 117824-04-1

Product Description: Dehydrojuncusol, a potent HCV inhibitor, targets HCV NS5A and is able to inhibit RNA replication of replicons harboring resistance mutations to anti-NS5A direct-acting antivirals. Dehydrojuncusol significantly inhibits HCV infection when added after virus inoculation of HCV genotype 2a (EC50=1.35 µM)[1].

Applications: COVID-19-anti-virus

Formula: C18H16O2

References: [1]Sahuc ME, et al. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from Juncus maritimus, Is a New Inhibitor of Hepatitis C Virus RNA Replication. J Virol. 2019;93(10):e02009-18. Published 2019 May 1.

CAS Number: 117824-04-1

Molecular Weight: 264.32

Research Area: Infection

Solubility: 10 mM in DMSO

Target: HCV;HCV Protease

• Artikelnummer: MEXHY-N8188-25
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-N8188-25
• Green Labware: Nein
• Verpackungseinheit: 25mg
• Mengeneinheit: STK